Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Drug Safety|October 30, 2020
Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort StudyClément Mathieu, Pierre Joly, Hélène Jacqmin-Gadda, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Factors associated with persistence of cholinesterase inhibitor treatments in the elderlyAntoine Pariente, Marion Pinet, Yola Moride, et al.
Scientific Reports|September 5, 2020
Impact of benzodiazepine consumption reduction on future burden of dementiaHélène Jacqmin-Gadda, Florian Guillet, Clément Mathieu, et al.
Diabetes Care|December 22, 2016
Risk of Myopathy Associated With DPP-4 Inhibitors in Combination With Statins: A Disproportionality Analysis Using Data From the WHO and French Spontaneous Reporting DatabasesVanessa Labat, Mickael Arnaud, Ghada Miremont-Salamé, et al.
General Hospital Psychiatry|May 15, 2020
Use of benzodiazepines non-compliant with guidelines in patients with psychiatric and non-psychiatric chronic disordersArnaud Panes, Hélène Verdoux, Annie Fourrier-Réglat, et al.
British Journal of Clinical Pharmacology|October 26, 2019
Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disordersArnaud Panes, Hélène Verdoux, Annie Fourrier-Réglat, et al.
Arthritis Research & Therapy|December 18, 2009
Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trialAlain Jacquet, Pierre-Olivier Girodet, Antoine Pariente, et al.
BMJ Open|August 2, 2017
Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in FranceAnne Bénard-Laribière, Antoine Pariente, Elodie Pambrun, et al.
British Journal of Clinical Pharmacology|February 22, 2026
Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle-AquitaineMaika Munech-Herran, Véronique Moysan, Bruno Lescarret, et al.
Journal of Clinical Medicine|November 25, 2020
The Burden of Potentially Inappropriate Medications in Chronic PolypharmacyJordan Guillot, Sandy Maumus-Robert, Alexandre Marceron, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Drug Safety|October 30, 2020
Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort StudyClément Mathieu, Pierre Joly, Hélène Jacqmin-Gadda, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Factors associated with persistence of cholinesterase inhibitor treatments in the elderlyAntoine Pariente, Marion Pinet, Yola Moride, et al.
Scientific Reports|September 5, 2020
Impact of benzodiazepine consumption reduction on future burden of dementiaHélène Jacqmin-Gadda, Florian Guillet, Clément Mathieu, et al.
Diabetes Care|December 22, 2016
Risk of Myopathy Associated With DPP-4 Inhibitors in Combination With Statins: A Disproportionality Analysis Using Data From the WHO and French Spontaneous Reporting DatabasesVanessa Labat, Mickael Arnaud, Ghada Miremont-Salamé, et al.
General Hospital Psychiatry|May 15, 2020
Use of benzodiazepines non-compliant with guidelines in patients with psychiatric and non-psychiatric chronic disordersArnaud Panes, Hélène Verdoux, Annie Fourrier-Réglat, et al.
British Journal of Clinical Pharmacology|October 26, 2019
Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disordersArnaud Panes, Hélène Verdoux, Annie Fourrier-Réglat, et al.
Arthritis Research & Therapy|December 18, 2009
Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trialAlain Jacquet, Pierre-Olivier Girodet, Antoine Pariente, et al.
BMJ Open|August 2, 2017
Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in FranceAnne Bénard-Laribière, Antoine Pariente, Elodie Pambrun, et al.
British Journal of Clinical Pharmacology|February 22, 2026
Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle-AquitaineMaika Munech-Herran, Véronique Moysan, Bruno Lescarret, et al.
Journal of Clinical Medicine|November 25, 2020
The Burden of Potentially Inappropriate Medications in Chronic PolypharmacyJordan Guillot, Sandy Maumus-Robert, Alexandre Marceron, et al.
Pageof 22